Can the Vanishing Stent Reappear?: Fix the Technique, or Fix the Device?

Affiliations

¹ Andreas Gruentzig Cardiovascular Center, Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: spencer.king@emoryhealthcare.org.
² Andreas Gruentzig Cardiovascular Center, Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.

Free article

Editorial

Spencer B King 3rd et al. J Am Coll Cardiol. 2017.

Free article

. 2017 Dec 12;70(23):2875-2877.

doi: 10.1016/j.jacc.2017.10.009. Epub 2017 Oct 31.

¹ Andreas Gruentzig Cardiovascular Center, Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: spencer.king@emoryhealthcare.org.
² Andreas Gruentzig Cardiovascular Center, Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.

No abstract available

Keywords: bioresorbable vascular scaffold; prognosis; randomized trial; stent; technique; thrombosis.

Comment on

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.
Kereiakes DJ, Ellis SG, Metzger C, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW; ABSORB III Investigators. Kereiakes DJ, et al. J Am Coll Cardiol. 2017 Dec 12;70(23):2852-2862. doi: 10.1016/j.jacc.2017.10.010. Epub 2017 Oct 31. J Am Coll Cardiol. 2017. PMID: 29100702 Clinical Trial.
Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials.
Stone GW, Abizaid A, Onuma Y, Seth A, Gao R, Ormiston J, Kimura T, Chevalier B, Ben-Yehuda O, Dressler O, McAndrew T, Ellis SG, Kereiakes DJ, Serruys PW. Stone GW, et al. J Am Coll Cardiol. 2017 Dec 12;70(23):2863-2874. doi: 10.1016/j.jacc.2017.09.1106. Epub 2017 Oct 31. J Am Coll Cardiol. 2017. PMID: 29100704 Clinical Trial.